Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma
Neeraj Saini(The University of Texas MD Anderson Cancer Center), Koichi Takahashi(The University of Texas MD Anderson Cancer Center), Nitin Jain(Parul University), Frederick L. Locke(Moffitt Cancer Center), Jason R. Westin(The University of Texas MD Anderson Cancer Center), Hun Ju Lee(The University of Texas MD Anderson Cancer Center), Swaminathan P. Iyer(The University of Texas MD Anderson Cancer Center), Roland L. Bassett(The University of Texas MD Anderson Cancer Center), Luis Fayad(The University of Texas MD Anderson Cancer Center), David A. Sallman(Moffitt Cancer Center), Feng Wang(The University of Texas MD Anderson Cancer Center), Romil Patel(The University of Texas MD Anderson Cancer Center), Loretta J. Nastoupil(The University of Texas MD Anderson Cancer Center), Mark R. Tanner(The University of Texas MD Anderson Cancer Center), Paolo Strati(The University of Texas MD Anderson Cancer Center), Sairah Ahmed(The University of Texas MD Anderson Cancer Center), Marco L. Davila(University of South Florida), Eric Padron(Moffitt Cancer Center), Richard E. Champlin(The University of Texas MD Anderson Cancer Center), Guilin Tang(The University of Texas MD Anderson Cancer Center), Elizabeth J. Shpall(Scripps MD Anderson Cancer Center), Sanam Loghavi(The University of Texas MD Anderson Cancer Center), Michael R. Green(Harvard University), Guillermo Garcia‐Manero(The University of Texas MD Anderson Cancer Center), Uri Greenbaum(Ben-Gurion University of the Negev), Sattva S. Neelapu(The University of Texas MD Anderson Cancer Center), P. Andrew Futreal(Wellcome Sanger Institute), Partow Kebriaei(The University of Texas MD Anderson Cancer Center), Kaberi Das(The University of Texas MD Anderson Cancer Center), Christopher R. Flowers(The University of Texas MD Anderson Cancer Center), Preetesh Jain(The University of Texas MD Anderson Cancer Center), Nancy Gillis(Moffitt Cancer Center), Michael Wang(St. Joseph Health System), David M. Swoboda(Moffitt Cancer Center), Junsheng Ma(The University of Texas MD Anderson Cancer Center), Kartik Devashish(The University of Texas MD Anderson Cancer Center), Michael D. Jain(Moffitt Cancer Center), Ranjit Nair(NewYork–Presbyterian Brooklyn Methodist Hospital), Raphaël Steiner(The University of Texas MD Anderson Cancer Center)
Cited by 72
Related Papers
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
The cancer genome
|Nature|2009|3.5k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
|Nucleic Acids Research|2010|2.3k